News from lonestar heart inc

May 05, 2014, 08:30 ET

LoneStar Heart achève la phase de recrutement pour son essai clinique randomisé de l'implant hydrogel Algisyl-LVR® dans le traitement de l'insuffisance cardiaque avancée

-- Des résultats sur six mois de l'étude multicentrique AUGMENT-HF devraient être présentés avant la fin de l'année...

May 05, 2014, 08:30 ET

LoneStar Heart Completes Recruitment for Randomized Clinical Trial of Algisyl-LVR® Hydrogel Implant for Advanced Heart Failure

 LoneStar Heart, Inc. today announced that it completed the patient recruitment phase of the company's AUGMENT-HF controlled randomized...

May 05, 2014, 08:30 ET

LoneStar Heart komplettiert Rekrutierung für randomisierte klinische Studie zum Algisyl-LVR® Hydrogel-Implantat für fortgeschrittene Herzinsuffizienz

-- Sechsmonatige Ergebnisse der AUGMENT-HF Multicenter-Studie sollen Ende des Jahres präsentiert werden  LoneStar Heart, Inc. hat...

May 05, 2014, 08:30 ET

LoneStar Heart completa el reclutamiento de un ensayo clínico aleatorio del implante de hidrogel Algisyl-LVR®

- LoneStar Heart completa el reclutamiento de un ensayo clínico aleatorio del implante de hidrogel Algisyl-LVR® para fallo cardiaco...

Nov 20, 2013, 12:29 ET

LoneStar Heart meldet positive Zwischenergebnisse zu Algisyl-LVR® für fortgeschrittene Herzinsuffizienz im Rahmen der aktuellen Klinikstudiensitzung der AHA

-- Ergebnisse einer randomisierten Studie an mehreren Standorten zeigen, dass eine Verstärkung der linken Herzkammer durch ein...

Nov 20, 2013, 08:59 ET

LoneStar Heart presenta los resultados interinos positivos de Algisyl-LVR® para fallo cardiaco avanzado

- LoneStar Heart presenta los resultados interinos positivos de Algisyl-LVR® para fallo cardiaco avanzado en las sesiones de los ensayos...

Nov 20, 2013, 08:30 ET

LoneStar Heart Reports Positive Interim Results of Algisyl-LVR® for Advanced Heart Failure at AHA's Late-Breaking Clinical Trials Sessions

 LoneStar Heart, Inc. today presented the interim results of its multicenter, randomized AUGMENT-HF clinical trial showing left ventricle...

Oct 09, 2012, 08:30 ET

LoneStar Heart Announces $20 Million Milestone Financing for Lead Product to Treat Heart Failure

LoneStar Heart Inc. today announced the completion of an up to $20 million milestone-based equity financing to support the clinical testing and...

Oct 01, 2012, 08:30 ET

LoneStar Heart Announces First Patient in AUGMENT-HF Clinical Trial of Algisyl-LVR™ for the Treatment of Heart Failure

 LoneStar Heart Inc., based here, today announced the first patient was treated in the company's international multi-center AUGMENT-HF clinical...

May 29, 2012, 08:30 ET

Heart Damage Repaired By Reprogramming Resident Fibroblasts into Functioning Heart Cells

 LoneStar Heart Inc., today announced the advancement of a new therapeutic strategy aimed at genetic reprogramming of cardiac fibroblasts...

Jan 24, 2012, 08:30 ET

LoneStar Heart Inc. Names Andrew J. Coats, M.D., and Mark Maciejewski to Its Board of Directors

 LoneStar Heart Inc., based here, today announced that it has elected Andrew J. Coats, M.D., and Mark Maciejewski to the company's board of...

Jan 16, 2012, 08:30 ET

LoneStar Heart Acquires Worldwide Exclusive Rights to New Class of Small Molecules That May Lead to New Treatments for Diabetes

 LoneStar Heart Inc., based here, today announced that it has acquired a worldwide exclusive license from the University of Texas...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge